A venture fund headquartered in Cambridge, MA makes Series A-stage investments of $200 K – $500 K. Follow on funding is coordinated through syndication and can range from $0.5 – 5 M. The firm focuses on the healthcare IT, digital health, and suppliers and engineering sectors, and prefers companies located in the US. Companies should be in the early stages of revenue production and exhibit some market traction and potential for global expansion. The firm will make about 6 new investments over the next 12 months.
The firm looks for enterprise technology plays that incorporate proprietary algorithms for data mining, machine learning, connected devices, virtual reality, and other technologies to create new systems. Past investments include biomedical and genomics data analytics platforms. They would consider wearable or medical devices that incorporate sophisticated software or connectivity.
The firm seeks experienced management teams with a vision for the future. The firm can take a board seat when they have specific expertise in the area, and does not have an equity target. Initial revenue generation and evidence of market strength is desired.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a comment